Gambit Bio, founded by Tiffany Ma, aims to revolutionize cancer diagnostics with a low-cost, early-stage detection tool, addressing the global challenge of timely cancer diagnosis, especially in low-income countries.

The company's innovative lateral flow tests, utilizing proprietary biomarkers, are designed for home use or at general physician offices, aiming to improve early detection and challenge the perception of cancer as a fatal disease.

Watch GambitBio founder, Tiffany Ma, give a revolutionary introduction to GambitBio’s early cancer diagnostic tool.